Dementia News and Research

Latest Dementia News and Research

Study sheds new light on host-pathogen interactions and long-term consequences of brain infections

A team led by Prof Kiavash Movahedi has mapped in detail how the immune system acts against pathogens invading the brain.

12 Oct 2022

Cell-free DNA circulating in the blood may signal early signs of dementia and frailty

In a long-term prospective study of more than 600 older participants, Johns Hopkins Medicine researchers say they have evidence that higher levels of cell-free DNA circulating in the blood may signal increased risk of chronic inflammation associated with early signs of frailty and dementia.

11 Oct 2022

Review on COVID-19 biomedical waste-derived microplastic toxicity

In a new study, researchers reviewed existing literature on the biomedical waste source, elements, and the recent upsurge of microplastics during the SARS-CoV-2 pandemic.

11 Oct 2022

Timely COVID-19 boosters may prevent care facility outbreaks

A new study examines vaccine efficacy during an outbreak of the SARS-CoV-2 Delta variant in a long-term care facility.

11 Oct 2022

Brain changes can be studied in very early stages of neurodegenerative diseases

Many changes take place in the brain long before symptoms appear. This has been shown in mice in two studies of prion diseases in which the brain gradually deteriorates.

10 Oct 2022

COVID‐19 pathology across different tissues

Researchers investigated COVID-19 pathophysiology in multiple tissues, including the lungs, kidneys, heart, and brain, for a deeper understanding of its acute and long‐term symptoms.

7 Oct 2022

People with schizophrenia are 2.5 times more likely to develop dementia

People with psychotic disorders such as schizophrenia are 2.5 times more likely than those without a psychotic disorder to eventually develop dementia, according to a review of evidence led by UCL researchers.

6 Oct 2022

The neuroprotective potential of Cannabis sativa L. against Alzheimer's disease

A recent study assesses the neuroprotective potential of the active constituents of cannabis in treating dementia and Alzheimer's disease.

6 Oct 2022

Omega-3 levels could play a role in improving cognitive resilience in middle-aged people

An exploratory study suggests that people who eat more foods with omega-3 fatty acids in midlife may have better thinking skills and even better brain structure than people who eat few foods with the fatty acids.

5 Oct 2022

Consuming more omega-3s associated with better brain health and cognition in middle age

Eating cold-water fish and other sources of omega-3 fatty acids may preserve brain health and enhance cognition in middle age, new evidence indicates.

5 Oct 2022

Decline in specific protein levels linked to Alzheimer’s disease, not buildup of amyloid plaques

New research from the University of Cincinnati bolsters a hypothesis that Alzheimer's disease is caused by a decline in levels of a specific protein, contrary to a prevailing theory that has been recently called into question.

5 Oct 2022

Viagra and Cialis may not be suitable candidates for treating dementia, NIH DREAM study shows

Results from the National Institutes of Health's Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study show that sildenafil (Viagra) and tadalafil (Cialis) may not be suitable candidates for treating dementia.

4 Oct 2022

Eligibility criteria lack clarity, justification for excluding people with disabilities from clinical trials

Despite constituting the largest minority group in the U.S. and expressing interest in participating in clinical trials, people with disabilities remain excluded.

3 Oct 2022

Study: Fewer Black, Hispanic and Asian patients qualify for treatments that slow Alzheimer's progression

The development of anti-amyloid monoclonal antibodies that may slow the progression of Alzheimer's disease by breaking down amyloid plaques, a hallmark of the disease, has brought fresh hope to aging populations and the doctors who treat them.

3 Oct 2022

New algorithm may help predict the risk of Alzheimer's dementia

When people participate in studies of aging, they often want to know what their individual risks of developing dementia from Alzheimer's disease are. Washington University researchers have developed an algorithm that can help provide them with information about what their risks may be.

30 Sep 2022

Researchers compare end-of-life care in persons with and without dementia

Researchers have known that race and ethnicity play a role in the intensity of medical care at the end of life, but the difference is more pronounced among individuals with dementia, the researchers found.

30 Sep 2022

Alzheimer’s researchers highlight the need for inclusive clinical trials

Enrolling representative populations in clinical trials for Alzheimer's disease is critical for finding treatments that will be safe and effective for all patients. African Americans and Latinos are disproportionately affected by this disease yet are substantially underrepresented in trials of promising therapies. For example, an analysis of data from more than 100 clinical trials testing new treatments for Alzheimer's disease found that only 12% of participants were of any non-White race or Hispanic ethnicity.

30 Sep 2022

Researchers find link between metabolism and dementia-related brain measures

Every three seconds, someone in the world is diagnosed with dementia. And while there is no known cure, changes in the brain can occur years before a dementia diagnosis.

30 Sep 2022

Increased risk for all-cause dementia in people who abstain from alcohol

Alcohol abstinence increases the risk for dementia in later life, according to a recent study published in the journal Addiction. Furthermore, neuroimaging records suggest that even low alcohol consumption levels could harm brain health, as does the dose-response relationship between alcohol use and systemic diseases, such as metabolic diseases and certain cancers.

30 Sep 2022

Artificial intelligence used to predict hospitalization outcomes of geriatric patients with dementia

By using artificial intelligence, Houston Methodist researchers are able to predict hospitalization outcomes of geriatric patients with dementia on the first or second day of hospital admission.

29 Sep 2022

Dementia News and Research

Latest Dementia News and Research

Study sheds new light on host-pathogen interactions and long-term consequences of brain infections

Cell-free DNA circulating in the blood may signal early signs of dementia and frailty

Review on COVID-19 biomedical waste-derived microplastic toxicity

Timely COVID-19 boosters may prevent care facility outbreaks

Brain changes can be studied in very early stages of neurodegenerative diseases

COVID‐19 pathology across different tissues

People with schizophrenia are 2.5 times more likely to develop dementia

The neuroprotective potential of Cannabis sativa L. against Alzheimer's disease

Omega-3 levels could play a role in improving cognitive resilience in middle-aged people

Consuming more omega-3s associated with better brain health and cognition in middle age

Decline in specific protein levels linked to Alzheimer’s disease, not buildup of amyloid plaques

Viagra and Cialis may not be suitable candidates for treating dementia, NIH DREAM study shows

Eligibility criteria lack clarity, justification for excluding people with disabilities from clinical trials

Study: Fewer Black, Hispanic and Asian patients qualify for treatments that slow Alzheimer's progression

New algorithm may help predict the risk of Alzheimer's dementia

Researchers compare end-of-life care in persons with and without dementia

Alzheimer’s researchers highlight the need for inclusive clinical trials

Researchers find link between metabolism and dementia-related brain measures

Increased risk for all-cause dementia in people who abstain from alcohol

Artificial intelligence used to predict hospitalization outcomes of geriatric patients with dementia

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Dementia News and Research

Latest Dementia News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in